• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Emergency department adherence to American Heart Association guidelines for blood pressure management in acute ischemic stroke.急诊科对美国心脏协会急性缺血性脑卒中血压管理指南的遵循情况。
Stroke. 2012 Feb;43(2):557-9. doi: 10.1161/STROKEAHA.111.637983. Epub 2011 Oct 27.
2
Poor guideline adherence in a real-world evaluation of hypertensive emergency management.真实世界中高血压急症管理的指南遵循度较差。
Am J Emerg Med. 2022 Jan;51:46-52. doi: 10.1016/j.ajem.2021.09.073. Epub 2021 Oct 4.
3
Aggressive blood pressure-lowering treatment before intravenous tissue plasminogen activator therapy in acute ischemic stroke.急性缺血性卒中患者在接受静脉注射组织型纤溶酶原激活剂治疗前进行强化降压治疗。
Arch Neurol. 2008 Sep;65(9):1174-8. doi: 10.1001/archneur.65.9.1174.
4
Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR).静脉溶栓治疗缺血性卒中时血压、抗高血压治疗与预后的关系:来自卒中溶栓安全实施-国际卒中溶栓登记研究(SITS-ISTR)的回顾性分析
Stroke. 2009 Jul;40(7):2442-9. doi: 10.1161/STROKEAHA.109.548602. Epub 2009 May 21.
5
Antihypertensives are administered selectively in emergency department patients with subarachnoid hemorrhage.降压药在急诊蛛网膜下腔出血患者中是有选择性使用的。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):1225-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.02.015. Epub 2012 Apr 10.
6
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.紧急医疗服务医院预先通知与急性缺血性卒中评估及治疗的改善相关。
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):514-22. doi: 10.1161/CIRCOUTCOMES.112.965210. Epub 2012 Jul 10.
7
Overuse of antihypertensives in patients with acute ischemic stroke.急性缺血性脑卒中患者抗高血压药物的过度使用。
South Med J. 2006 Nov;99(11):1230-3. doi: 10.1097/01.smj.0000232214.06335.ca.
8
Use of antihypertensive agents in the management of patients with acute ischemic stroke.抗高血压药物在急性缺血性脑卒中患者管理中的应用。
Neurology. 2004 Jul 27;63(2):318-23. doi: 10.1212/01.wnl.0000129831.79811.82.
9
Racial Disparities in Blood Pressure at Time of Acute Ischemic Stroke Presentation: A Population Study.急性缺血性脑卒中发病时的血压种族差异:一项人群研究。
J Am Heart Assoc. 2024 May 7;13(9):e032645. doi: 10.1161/JAHA.123.032645. Epub 2024 May 3.
10
Higher prehospital blood pressure prolongs door to needle thrombolysis times: a target for quality improvement?较高的院前血压会延长门到针溶栓时间:这是质量改进的一个目标吗?
Am J Emerg Med. 2016 Jul;34(7):1268-72. doi: 10.1016/j.ajem.2016.04.023. Epub 2016 Apr 16.

引用本文的文献

1
Feasibility evaluation of non-invasive cardiac function technology during echocardiography-based cardiac stress testing.基于超声心动图的心脏应激试验中非侵入性心脏功能技术的可行性评估。
J Clin Monit Comput. 2020 Aug;34(4):655-661. doi: 10.1007/s10877-019-00354-4. Epub 2019 Jul 13.
2
Early antihypertensive treatment and clinical outcomes in acute ischemic stroke: subgroup analysis by baseline blood pressure.急性缺血性脑卒中的早期降压治疗与临床结局:基于基线血压的亚组分析。
J Hypertens. 2018 Jun;36(6):1372-1381. doi: 10.1097/HJH.0000000000001690.
3
Emergency Department Length of Stay and Outcome after Ischemic Stroke.缺血性中风后的急诊科住院时间及预后
J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2167-2173. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.040. Epub 2017 May 24.
4
Use of Preoperative Testing and Physicians' Response to Professional Society Guidance.术前检查的使用及医生对专业学会指南的反应。
JAMA Intern Med. 2015 Aug;175(8):1352-9. doi: 10.1001/jamainternmed.2015.2081.
5
Race/Ethnicity and overuse of care: a systematic review.种族/民族与医疗过度使用:一项系统综述
Milbank Q. 2015 Mar;93(1):112-38. doi: 10.1111/1468-0009.12107.
6
Old habits die hard: a nationwide utilization study of short-acting nifedipine in Taiwan.积习难改:台湾地区短效硝苯地平的全国性使用情况研究
PLoS One. 2014 Mar 17;9(3):e91858. doi: 10.1371/journal.pone.0091858. eCollection 2014.

本文引用的文献

1
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.血管紧张素受体阻滞剂坎地沙坦治疗急性脑卒中(SCAST):一项随机、安慰剂对照、双盲试验。
Lancet. 2011 Feb 26;377(9767):741-50. doi: 10.1016/S0140-6736(11)60104-9.
2
Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study.白人人群中的中风发病率正在下降,但黑人人群中却没有:辛辛那提/北肯塔基州中风研究的基于人群的中风发病率时间趋势的估计。
Stroke. 2010 Jul;41(7):1326-31. doi: 10.1161/STROKEAHA.109.575043. Epub 2010 May 20.
3
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.替米沙坦对急性轻度缺血性卒中患者功能转归、复发及血压的影响:PRoFESS亚组分析
Stroke. 2009 Nov;40(11):3541-6. doi: 10.1161/STROKEAHA.109.555623. Epub 2009 Sep 24.
4
Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.卒中后立即控制高血压和低血压(CHHIPS):一项随机、安慰剂对照、双盲试验
Lancet Neurol. 2009 Jan;8(1):48-56. doi: 10.1016/S1474-4422(08)70263-1. Epub 2008 Dec 4.
5
Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome.缺血性中风急性期血压下降与脑损伤及中风预后不良相关。
Stroke. 2004 Feb;35(2):520-6. doi: 10.1161/01.STR.0000109769.22917.B0. Epub 2004 Jan 15.
6
Trials on blood pressure-lowering and secondary stroke prevention.血压降低及继发性中风预防试验。
Am J Cardiol. 2003 May 22;91(10A):3G-8G. doi: 10.1016/s0002-9149(03)00226-1.
7
Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association.缺血性卒中患者早期管理指南:美国卒中协会卒中委员会的科学声明
Stroke. 2003 Apr;34(4):1056-83. doi: 10.1161/01.STR.0000064841.47697.22.
8
Blood pressure and clinical outcomes in the International Stroke Trial.国际卒中试验中的血压与临床结局
Stroke. 2002 May;33(5):1315-20. doi: 10.1161/01.str.0000014509.11540.66.

急诊科对美国心脏协会急性缺血性脑卒中血压管理指南的遵循情况。

Emergency department adherence to American Heart Association guidelines for blood pressure management in acute ischemic stroke.

机构信息

Departments of Emergency Medicine, University of Cincinnati, Cincinnati, OH 45267-0769, USA.

出版信息

Stroke. 2012 Feb;43(2):557-9. doi: 10.1161/STROKEAHA.111.637983. Epub 2011 Oct 27.

DOI:10.1161/STROKEAHA.111.637983
PMID:22033993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3265646/
Abstract

BACKGROUND AND PURPOSE

Severely elevated blood pressure (BP) and aggressive BP reduction are both associated with poor outcome in acute ischemic stroke (AIS). In nontissue-type plasminogen activator patients, the American Heart Association recommends antihypertensive therapy only if BP is ≥ 220/120 mm Hg with a goal of 15% to 25% reduction in the first 24 hours. We hypothesized that patients with AIS often receive antihypertensives in the emergency department below the recommended threshold and that BP reduction is often >20%.

METHODS

In 2005, AIS cases were ascertained at all 16 hospitals in Greater Cincinnati. BP was recorded at emergency department presentation and before and after antihypertensive treatment. Hypertension was defined as BP ≥ 220/120 mm Hg. Chi-square and Mann-Whitney U tests were used for comparisons.

RESULTS

A total of 1739 patients with AIS met inclusion criteria. Median age was 72 years with 43% male and 25% black. Of 218 treated with antihypertensives, 65 (30.0%) met treatment criteria immediately before treatment. Treated patients were younger (66 versus 73 years, P<0.001) with greater stroke severity than untreated patients (National Institutes of Health Stroke Scale score 4 versus 3, P=0.028). Median change in systolic BP was -25 mm Hg (range, -96 to 25 mm Hg). Median percentage change in systolic BP was -12.3% (range, -49.2% to 16.1%). Systolic BP decreased > 20% in 52 treated patients (23.7%).

CONCLUSIONS

Only one third of patients with AIS treated with antihypertensives met American Heart Association-recommended treatment criteria, and the rate of change of BP was frequently greater than recommended. Further studies are warranted to determine the impact of practice patterns on AIS outcomes.

摘要

背景与目的

严重的血压升高(BP)和积极的 BP 降低都与急性缺血性脑卒中(AIS)的不良预后有关。对于非组织型纤溶酶原激活剂患者,美国心脏协会建议仅在血压≥220/120mmHg 时进行降压治疗,目标是在 24 小时内降低 15%至 25%。我们假设 AIS 患者在急诊科接受的降压治疗通常低于推荐阈值,且血压降低通常>20%。

方法

2005 年,在辛辛那提大都市区的所有 16 家医院确定了 AIS 病例。在急诊科就诊时、降压治疗前后记录血压。高血压定义为血压≥220/120mmHg。使用卡方检验和曼-惠特尼 U 检验进行比较。

结果

共有 1739 例 AIS 患者符合纳入标准。中位年龄为 72 岁,男性占 43%,黑人占 25%。218 例接受降压治疗的患者中,65 例(30.0%)在治疗前立即符合治疗标准。治疗组患者较未治疗组更年轻(66 岁 vs 73 岁,P<0.001),且脑卒中严重程度更高(美国国立卫生研究院脑卒中量表评分 4 分 vs 3 分,P=0.028)。收缩压的中位变化为-25mmHg(范围:-96 至 25mmHg)。收缩压的中位百分比变化为-12.3%(范围:-49.2%至 16.1%)。52 例接受治疗的患者中,收缩压降低>20%(23.7%)。

结论

仅三分之一接受降压治疗的 AIS 患者符合美国心脏协会推荐的治疗标准,且血压变化率经常超过推荐值。需要进一步研究以确定实践模式对 AIS 结局的影响。